Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 2
2006 3
2009 2
2010 1
2011 5
2012 8
2013 5
2014 2
2015 6
2016 4
2017 3
2018 2
2019 6
2020 3
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
The integrated landscape of driver genomic alterations in glioblastoma.
Frattini V, Trifonov V, Chan JM, Castano A, Lia M, Abate F, Keir ST, Ji AX, Zoppoli P, Niola F, Danussi C, Dolgalev I, Porrati P, Pellegatta S, Heguy A, Gupta G, Pisapia DJ, Canoll P, Bruce JN, McLendon RE, Yan H, Aldape K, Finocchiaro G, Mikkelsen T, Privé GG, Bigner DD, Lasorella A, Rabadan R, Iavarone A. Frattini V, et al. Among authors: pellegatta s. Nat Genet. 2013 Oct;45(10):1141-9. doi: 10.1038/ng.2734. Epub 2013 Aug 5. Nat Genet. 2013. PMID: 23917401 Free PMC article.
Transforming fusions of FGFR and TACC genes in human glioblastoma.
Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, Castano A, Liu EM, Reichel J, Porrati P, Pellegatta S, Qiu K, Gao Z, Ceccarelli M, Riccardi R, Brat DJ, Guha A, Aldape K, Golfinos JG, Zagzag D, Mikkelsen T, Finocchiaro G, Lasorella A, Rabadan R, Iavarone A. Singh D, et al. Among authors: pellegatta s. Science. 2012 Sep 7;337(6099):1231-5. doi: 10.1126/science.1220834. Epub 2012 Jul 26. Science. 2012. PMID: 22837387 Free PMC article.
B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres.
Nehama D, Di Ianni N, Musio S, Du H, Patané M, Pollo B, Finocchiaro G, Park JJH, Dunn DE, Edwards DS, Damrauer JS, Hudson H, Floyd SR, Ferrone S, Savoldo B, Pellegatta S, Dotti G. Nehama D, et al. Among authors: pellegatta s. EBioMedicine. 2019 Sep;47:33-43. doi: 10.1016/j.ebiom.2019.08.030. Epub 2019 Aug 26. EBioMedicine. 2019. PMID: 31466914 Free PMC article.
NG2/CSPG4 in glioblastoma: about flexibility.
Finocchiaro G, Pellegatta S. Finocchiaro G, et al. Among authors: pellegatta s. Neuro Oncol. 2019 Jun 10;21(6):697-698. doi: 10.1093/neuonc/noz055. Neuro Oncol. 2019. PMID: 30918960 Free PMC article. No abstract available.
High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient.
Anghileri E, Di Ianni N, Paterra R, Langella T, Zhao J, Eoli M, Patanè M, Pollo B, Cuccarini V, Iavarone A, Rabadan R, Finocchiaro G, Pellegatta S. Anghileri E, et al. Among authors: pellegatta s. Cancer Immunol Immunother. 2021 Mar;70(3):831-842. doi: 10.1007/s00262-020-02769-4. Epub 2020 Nov 3. Cancer Immunol Immunother. 2021. PMID: 33140187
Perspectives for immunotherapy in glioblastoma treatment.
Finocchiaro G, Pellegatta S. Finocchiaro G, et al. Among authors: pellegatta s. Curr Opin Oncol. 2014 Nov;26(6):608-14. doi: 10.1097/CCO.0000000000000135. Curr Opin Oncol. 2014. PMID: 25210870 Review.
55 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page